PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A revolutionary new way of reversing certain cancers

2010-09-28
(Press-News.org) Australian and American scientists have found a way of shrinking tumours in certain cancers – a finding that provides hope for new treatments.

The cancers in question are those caused by a new class of genes known as 'microRNAs', produced by parts of the genome that, until recently, were dismissed as 'junk DNA'. While much is still unknown about microRNAs, it is clear that they can interfere with how our genes are 'read'.

The current finding identifies one particular microRNA (microRNA 380) that appears to disable the king of tumour suppressors, the P53 gene. So important is P53, that it is known as the 'guardian of the genome'. In order for a cell to become cancerous, P53 must either be mutated or otherwise disabled.

Dr Alex Swarbrick, from Sydney's Garvan Institute of Medical Research, Dr Susan Woods from Brisbane's Queensland Institute of Medical Research and Dr Andrei Goga from The University of California San Francisco chose to study neuroblastoma, a childhood cancer of the nervous system in which 99% of patients do not have mutations of the P53 gene.

The researchers found instead that neuroblastomas disable p53 by over-producing microRNA 380. When they blocked the microRNA, P53 production resumed, cancer cells died and tumours became much smaller. Their results are reported in the prestigious international journal Nature Medicine, online today.

"The revolutionary thing about this finding is that it's the first time anyone has blocked the growth of a primary tumour by the simple delivery of a microRNA inhibitor," said Swarbrick.

"By that, I mean we delivered the microRNA inhibitor in a way we might give it to a person – as a twice-weekly injection – not using some genetic trick. It's the closest thing to a clinical result that's yet been published."

"That, of course, makes this microRNA a potential therapeutic target for all cancers that depend on it."

"The other good news is that you don't find this microRNA in normal adult cells. It's very active while we are developing embryos, when cells need to divide very quickly, but after that it appears to get switched off. So by blocking it, you're effectively returning cells to normal."

"We still don't know why it gets switched on again in certain cancers. Apart from neuroblastomas, we often see it in brain tumours and in melanomas that don't have mutations in P53."

So how exactly does it work?

When a gene is transcribed or "read", in this case P53, a copy of the gene is made in RNA. In a normal cell, that P53 RNA carries the instructions to make P53 proteins, which in turn carry out the tumour suppressor function in cells.

"MicroRNAs act to control the production of proteins – the molecules that do the work in cells," explained Swarbrick.

"In the cancers we are discussing, our microRNA binds with P53 RNA, preventing it from making proteins. That effectively reduces the number of P53 proteins in a cell and allows the tumour to grow."

"Understanding that certain cancers appear to be regulated like this gives us a new avenue to explore in their treatment."

While this finding is at an early research stage, it holds much promise for the future treatment of early childhood neuroblastomas and other microRNA- induced cancers.

INFORMATION:

ABOUT GARVAN

The Garvan Institute of Medical Research was founded in 1963. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with nearly 500 scientists, students and support staff. Garvan's main research programs are: Cancer, Diabetes & Obesity, Immunology and Inflammation and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.

MEDIA ENQUIRIES
Alison Heather
Science Communications Manager
Garvan Institute of Medical Research
+61 2 9295 8128
+61 434 071 326
a.heather@garvan.org.au

END



ELSE PRESS RELEASES FROM THIS DATE:

2010 AAO-HNSF miniseminars: Tuesday, Sept. 28, 2010

2010-09-28
Boston, MA – The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 26-29, 2010, in Boston, MA. Featuring more than 305 scientific research sessions, 594 posters, and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking science and medical news. Reporters will have access to the latest research and clinical advances ...

2010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010

2010-09-28
PACU PTH Facilitates Safe Outpatient Total Thyroidectomy Presenters: William Pechter, MS; David Steward, MD; Jeffrey Houlton, MD; Naresh Panda, MS, FRCSEd Time: 8: 32 am Location: 254 Boston, MA – A study was performed reviewing thyroidectomies from March 2008 to November 2009, to determine if a serum parathyroid hormone (PTH)-based discharge algorithm can be used to safely facilitate outpatient total thyroidectomy. In a presentation at the 2010 AAO-HNSF Annual Meeting & OTO EXPO in Boston, researchers revealed that 180 patients (mean age 48.9, 83.3% female) underwent ...

More developing countries show universal access to HIV/AIDS services is possible

2010-09-28
28 September 2010 | GENEVA / NAIROBI / WASHINGTON D.C – Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards Universal Access by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care. The report assessed ...

GOES-13 Satellite sees Lisa a tropical storm ... for now

GOES-13 Satellite sees Lisa a tropical storm ... for now
2010-09-28
The GOES-13 satellite has been keeping an eye on Tropical Storm Lisa and watched her birth, graduation to depression then tropical storm and back to depression. Now, Lisa has grown back to tropical storm status, but it may be short-lived. At 11 a.m. EDT on Friday, Sept. 24, Tropical Storm Lisa had maximum sustained winds near 50 mph and she may strengthen and weaken over the weekend, but by Sunday colder waters will zap her energy source and she is forecast to be a depression. Meanwhile, on Sept. 24, she was still frolicking in the eastern Atlantic, about 320 miles ...

Scientists discover gene linked to a common form of migraine

2010-09-28
Montreal, September 26th, 2010 at 1:00 PM – An international study led by scientists at Université de Montréal and University of Oxford, has identified a gene associated with common migraines. Their findings show that a mutation in the KCNK18 gene inhibits the function of a protein called TRESK. TRESK normally plays a key role in nerve cell communication. Published today in Nature Medicine, this study may have implications for people who suffer from recurrent headaches, which include more than six million Canadians. Previously, genes for migraine have been found only ...

Single electron reader opens path for quantum computing

2010-09-28
A team led by engineers and physicists at the University of New South Wales (UNSW) in Sydney, Australia, have developed one of the key building blocks needed to make a quantum computer using silicon: a "single electron reader". Their work was published today in Nature. Quantum computers promise exponential increases in processing speed over today's computers through their use of the "spin", or magnetic orientation, of individual electrons to represent data in their calculations. In order to employ electron spin, the quantum computer needs both a way of changing the ...

2010 AAO-HNSF miniseminars: Monday, Sept. 27, 2010

2010-09-28
Boston, MA – The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 26-29, 2010, in Boston, MA. Featuring more than 305 scientific research sessions, 594 posters, and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking science and medical news. Reporters will have access to the latest research and clinical advances ...

2010 AAO-HNSF new research daily highlights: Monday, Sept. 27, 2010

2010-09-28
Inner Ear Stem-Cell Transplantation in Cochlear Cultures Presenters: Dylan K. Chan, MD, PhD; Saku Sinkkonen, MD, PhD; Alan G. Cheng, MD; Stefan Heller, PhD Time: 9:46 am Location: Room 209 Boston, MA – Researchers have developed an in vitro system to investigate hair-cell regeneration techniques and evaluate the ability of transplanted inner-ear stem-cell spheres to integrate into the organ of Corti and differentiate into mature hair cells. In a presentation at the 2010 AAO-HNSF Annual Meeting & OTO EXPO in Boston, researchers revealed that co-culture between inner-ear ...

Gut-invading worms turn enemy T cells into friends

2010-09-28
Intestinal worms sidestep the immune system by inducing the development of suppressive T cells, according to a study published on September 27th in the Journal of Experimental Medicine (www.jem.org). Immune T cells are essential for the clearance of invading microbes, including intestinal worms, but turning off immune responses is essential for avoiding collateral tissue destruction. This job falls in part to a population of suppressive T cells called regulatory T (T reg) cells. A team of researchers, led by Rick Maizels at the University of Edinburgh, show that gut-invading ...

Acupuncture not effective in stroke recovery

2010-09-28
Acupuncture does not appear to aid in stroke recovery, according to a new study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091113.pdf Acupuncture is often used to supplement traditional stroke rehabilitation, although its effectiveness is uncertain. It is necessary to have evidence of effectiveness from rigorous randomized clinical trials to recommend routine therapeutic use. This study, perhaps the most comprehensive to date as it includes trials published in English language and Asian journals, was ...

LAST 30 PRESS RELEASES:

Study reveals how bacteria in tumors drive treatment resistance in cancer

Language barriers in health care have fallen – but not online, study shows

What vibrating molecules might reveal about cell biology

UIC study of blood stem cells asks: Can we slow aging on a cellular level?

Palm oil isn’t necessarily less sustainable than other oils, say conservationists

A hitchhiker's guide to the galaxy of space immunology

Mysterious glow in Milky Way could be evidence of dark matter

Pathogenic germline variants in cancer susceptibility genes

Discrimination experiences among medical students

Pickleball-related ocular injuries among patients presenting to emergency departments

Ganoderma lucidum alleviates high-fat diet-induced hepatic lipotoxicity via modulating the unfolded protein response and endoplasmic reticulum-phagy

Circularly polarized luminescence enhancement in rare-earth MOFs due to framework chirality and host–guest energy transfer

Nickel-substituted polyoxometalate-CdS single-cluster photocatalysts for efficient plastic waste degradation coupled with H2 production

Polyoxometalate hybrid comb-like crosslinked polymer networks for anhydrous proton conductors

A research team at the Universitat Jaume I creates a robotic platform with artificial intelligence to accelerate the transition to a sustainable industry

Binghamton University researchers use nanotubes to improve blood flow in bioengineered tissues

Elizabeth Haines, DO, MSc, FACEP, appointed Chief Operating Officer of Mount Sinai Kravis Children’s Hospital and Senior Vice President of Pediatric Services, Mount Sinai Health System

Just knowing help is there makes all the difference

Gut microbiome affects alcohol preference by influencing brain’s reward system

Manchurian walnut tree holds key to eco-friendly weed control

After cancer: study explores caring-healing modalities for survivors

The paper industry can become more energy-efficient with a new measurement method

SEOULTECH researchers develop VFF-Net, a revolutionary alternative to backpropagation that transforms AI training

Pusan National University study finds pollution shifts rainfall from land to sea in Southeast Asia

Korea University researchers advance orthodontics with AI-assisted growth prediction

New low-cost, efficient single-photon source for powering future quantum internet

Helping farmers, boosting biofuels

Air pollution during pregnancy is associated with slower brain maturation in newborns

Expanding farming capabilities will not close Africa’s ‘hidden hunger’ gaps

Time crystals could power future quantum computers

[Press-News.org] A revolutionary new way of reversing certain cancers